logo
  • About
  • Plus Three
  • Power Trip
  • Store
  • Donate
  • Search

Kasia Malinowska and Bethany Medley

Kasia Malinowska is the founding director of the Global Drug Policy programme at the Open Society Foundations. Her work has appeared in The Lancet, the British Medical Journal, and the International Journal on Drug Policy. She lives in New York.

Bethany Medley is an intern on the Global Drug Policy programme at the Open Society Foundations. She lives in New York City.


[molongui_author_posts count=100 list_divider=”yes” show_date=”yes”]

How has Western influence changed the traditional use of iboga in Gabon? | Part 3

December 6, 2017

The Ibogaine Conversation Part 3 | What is the authentic Bwiti tradition? The answer I got was that this idea of authenticity is an odd idea. It’s a very Western idea. Bwiti considers itself as a culture that’s changing.


We are Bwitists and Healers in Gabon. Here’s What We Think of the Global Interest in Iboga. | Part 4

December 11, 2017

The Ibogaine Conversation Part 4 | The Western world cannot receive the benefits of iboga if they don’t try to understand and assimilate the traditional approach.


Talking Ibogaine Research for Opioid Addiction with Thomas Kingsley Brown | Part 5

December 12, 2017

The Ibogaine Conversation Part 5 | Thomas Kingsley Brown, PhD, studied the long-term outcomes of people who received ibogaine for the treatment of opioid addiction. We talked about the results.


Patrick Kroupa, hacker and ex-heroin ‘junkie’, on microdosing and the medicalization of ibogaine | Part 6

December 13, 2017

The Ibogaine Conversation Part 6 | My experience with heroin went from age 14 up to age 30, and taking ibogaine was as close to a miracle as I have ever experienced in my life.


Former Underground Provider, Dimitri Mugianis, on the Regulation of Ibogaine | Part 7

December 18, 2017

The Ibogaine Conversation Part 7 | "Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it's all a revolving door."


How Not to Do Ibogaine 101 with Juliana Mulligan | Part 8

December 19, 2017

The Ibogaine Conversation Part 8 | This is not a do-it-at-home type thing.


How Safe is Ibogaine? We Asked Clare Wilkins Who Has Facilitated Over 700 Treatments | Part 9

January 2, 2018

The Ibogaine Conversation Part 9 | Using ibogaine can be fatal if proper safety precautions aren’t taken.


Ibogaine Treatment Comes with Risks. We Had a Discussion About Safety with Medical Providers. | Part 10

January 3, 2018

The Ibogaine Conversation Part 10 | Unlike other psychedelic drugs, ibogaine is known to be potentially cardiotoxic. There are a number of fatalities associated with its use, and anyone considering working with it should be aware of the risks.


Is Ibogaine the Cure for Opioid Addiction? It’s Not That Simple. | Part 11

January 9, 2018

The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.


Humans of the Commission on Narcotic Drugs

March 12, 2018

Meet some of the people on the front lines of global drug reform at The Commission on Narcotic Drugs in Vienna.


Loading…

Join Our Newsletter

Independent reporting. Critical analysis. In your inbox.

Text

About
Donate

Store
Power Trip
Plus Three Podcast

Text

Media Requests
Send Us A Tip
Editorial Policy
Subscribe
Archive

Image

Text

Text

About
Donate

Store
Power Trip
Plus Three Podcast

Text

Media Requests
Send Us A Tip
Editorial Policy
Subscribe
Archive

Image

Psymposia is a 501(c)(3) non-profit media organization that offers critical perspectives on drugs, politics, and culture. We reject corporate advertising and rely on contributions from our readers and listeners. Click here to donate today.

Privacy. Terms of Use. © Psymposia, Inc. All Rights Reserved

Image

Text

About
Donate
Store
Power Trip
Podcast

Media Requests
Send Us A Tip

Editorial Policy
Subscribe
Archive

Privacy
Terms of Use

Psymposia is a 501(c)(3) non-profit media organization that offers leftist perspectives on drugs, politics, and culture. We reject corporate advertising and rely on contributions from our readers and listeners. Click here to donate today.

© Psymposia, Inc. All Rights Reserved

Image

Image

Text

About
Donate
Store
Power Trip
Podcast

Media Requests
Send Us A Tip

Editorial Policy
Subscribe
Archive

Privacy
Terms of Use

Psymposia is a 501(c)(3) non-profit media organization that offers leftist perspectives on drugs, politics, and culture. We reject corporate advertising and rely on contributions from our readers and listeners. Click here to donate today.

© Psymposia, Inc. All Rights Reserved

Image

  • About
  • Power Trip
  • Plus Three
  • Store
  • Support us on Patreon
  • Donate
  • Psychedelics
  • Corporadelic
  • Culture
  • Ethics
  • Series
  • Editorial Policies
  • Subscribe
  • Submissions
  • Send Us a Tip
  • Media Requests
  • Archive

Psymposia is a 501(c)(3) research non-profit with a mission to educate the public on psychedelic science and harm reduction.

Privacy Terms of Use

shiftnav-1

  • About
  • Plus Three
  • Power Trip
  • Store
  • Donate